STOCK TITAN

Delphx Cap Mkts Stock Price, News & Analysis

DPXCF OTC Link

Company Description

DelphX Capital Markets Inc. (OTCQB: DPXCF), also referenced as DelphX, is a technology and financial services company in the investment banking and securities dealing space. According to its public disclosures, the company focuses on developing and distributing the next generation of structured financial products that combine fixed-income and cryptocurrency-related features.

DelphX operates through a special purpose vehicle, Quantem LLC, which enables broker-dealers to offer new private placement securities. These securities are designed for qualified institutional buyers and other institutional accounts that seek structured exposure to corporate credit and digital assets. The company’s activities place it at the intersection of traditional finance and the evolving crypto-asset sector.

Core Products and Structure

DelphX states that its proprietary securities include two primary instruments:

  • Collateralized Put Options (CPOs), which are described as providing secured protection against rating downgrades of underlying corporate bonds and/or losses in cryptocurrency holdings.
  • Collateralized Reference Notes (CRNs), which enable investors to assume a capped rating-downgrade and/or cryptocurrency-loss exposure on an underlying security or cryptocurrency in exchange for potential returns.

All CPOs and CRNs are represented as fully collateralized instruments, with collateral held in custody by U.S. Bank. DelphX also notes that these instruments are proprietary products created and owned by DelphX Capital Markets Inc.

Quantem Crypto Securities (QCS) Program

DelphX has described the development of a Quantem Crypto Securities (QCS) platform, presented as a fully collateralized hedging solution for digital-asset treasuries and other institutional participants. The company has highlighted QCS as a mechanism intended to mitigate volatility and protect Bitcoin or other crypto-asset treasury holdings through structured, collateralized contracts.

In its public updates, DelphX has reported marketing efforts around QCS and interest from market participants. For example, it has indicated that a U.S. primary dealer has been evaluating a potential proof-of-concept collaboration aimed at deploying QCS within an existing digital-asset infrastructure, and that multiple digital-asset treasuries have been conducting due diligence and scenario testing on the QCS hedge program. The company also notes that there can be no assurance such implementations or transactions will occur.

Letter of Intent and Crypto-Treasury Focus

DelphX has announced a non-binding letter of intent with Belgravia Hartford Capital Inc. relating to what it describes as the first anticipated commercial transaction of its Quantem Crypto Security. Under the letter of intent, Belgravia is expected to become the first corporate purchaser of a QCS collateralized put option designed to protect and preserve corporate Bitcoin treasury holdings, subject to definitive agreements, regulatory approvals, market conditions, and other customary conditions. The company emphasizes that the letter of intent is non-binding, except for certain standard provisions, and may be terminated by either party.

DelphX also reports that Belgravia is expected to provide advisory and structuring support for the anticipated QCS launch, including assistance with program documentation, compliance processes, and onboarding coordination with a designated placement agent.

Capital Markets Activity

DelphX is listed on the TSX Venture Exchange under the symbol DELX and trades on the OTCQB market under the symbol DPXCF. The company has frequently used non-brokered private placements as a source of capital. In multiple announcements, DelphX has described offerings of units consisting of common shares and common share purchase warrants, with stated intentions to use net proceeds for working capital, corporate overhead, or general corporate purposes.

These placements typically involve a subscription price per unit and warrants exercisable at specified prices for a defined term. Certain offerings have included participation by insiders, which DelphX has identified as related party transactions under applicable securities regulations. The company has also disclosed instances of warrant extensions, subject to TSX Venture Exchange acceptance, and has referenced reliance on exemptions from formal valuation and minority approval requirements where the fair market value of the securities involved did not exceed a specified percentage of its market capitalization.

Custody and Collateralization

In its descriptions, DelphX consistently emphasizes that its CPOs and CRNs are fully collateralized and that collateral is held in custody by U.S. Bank. This structure is presented as central to the design of both its fixed-income and crypto-linked products, as well as to the QCS hedging program. The company positions this full-collateralization approach as a key characteristic of its structured offerings.

Corporate Governance and Options

DelphX has reported the use of stock options as part of its compensation and incentive arrangements. The board of directors has approved grants of options to eligible participants under its stock option plan, with specified maturities and exercise prices. The company has also disclosed transitions in its Chief Financial Officer role, including the departure of one CFO to pursue another opportunity and the appointment of an individual who previously served in that role.

Regulatory and Risk Disclosures

In its news releases, DelphX notes that completion of its private placements and warrant amendments is subject to TSX Venture Exchange approval and that securities issued are subject to hold periods. The company also references regulatory frameworks such as Multilateral Instrument 61-101 and TSXV Policy 5.9 in connection with related party transactions.

With respect to its crypto-related activities, DelphX has highlighted that the crypto market is high risk and subject to significant volatility. It presents its QCS program as a fully collateralized hedging solution intended to address risk management needs in the digital-asset sector, while acknowledging that there can be no assurance that contemplated collaborations or implementations will be completed.

Business Context

Within the finance and insurance sector, and more specifically within investment banking and securities dealing, DelphX describes itself as focused on structured products that blend elements of corporate credit and cryptocurrency exposure. Its disclosures emphasize product design, collateralization, and capital markets activity rather than detailed financial metrics or geographic expansion. Investors reviewing DPXCF stock typically consider the company’s progress in commercializing its proprietary CPO, CRN, and QCS offerings, as well as its ability to secure institutional participation and regulatory approvals for its programs.

Stock Performance

$—
0.00%
0.00
Last updated:
-27.82 %
Performance 1 year

SEC Filings

No SEC filings available for Delphx Cap Mkts.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

MAR
15
March 15, 2026 Financial

Hold period expiry

Hold period ends for securities issued in private placement
APR
23
April 23, 2026 Financial

Hold period expiration

Four-month plus one day hold on private placement securities ends (issued 2025-12-22).
MAY
24
May 24, 2026 Financial

Securities hold expiry

4-month-plus-one-day hold on securities expires (calculated from assumed issuance/closing)
MAY
31
May 31, 2026 Financial

Hold expiry (4 months+1 day)

Resale restriction on issued securities expires; units issued Jan 30, 2026
JUN
29
June 29, 2026 Financial

Warrant exercise expiry

Expiry of 5,430,250 warrants exercisable at $0.15 per share
AUG
25
August 25, 2026 Financial

Extension of $0.30 warrant expiry

TSXV approval sought to extend 4,825,715 $0.30 warrants
AUG
30
August 30, 2026 Financial

Extension of $0.15 warrant expiry

TSXV approval sought to extend 2,825,000 $0.15 warrants
NOV
01
November 1, 2026 Financial

Warrant expiration

Expiration of 3.48M share purchase warrants exercisable at $0.20
FEB
01
February 1, 2027 Financial

Stock options expiration

FEB
01
February 1, 2027 Financial

Warrant expiration

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Delphx Cap Mkts (DPXCF)?

The current stock price of Delphx Cap Mkts (DPXCF) is $0.0563 as of January 28, 2026.

What is the market cap of Delphx Cap Mkts (DPXCF)?

The market cap of Delphx Cap Mkts (DPXCF) is approximately 8.8M. Learn more about what market capitalization means .

What does DelphX Capital Markets Inc. do?

DelphX Capital Markets Inc. describes itself as a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, it enables broker-dealers to offer new private placement securities that combine fixed-income and cryptocurrency-related features.

What are DelphX Collateralized Put Options (CPOs)?

According to DelphX, Collateralized Put Options (CPOs) are proprietary securities that provide secured protection against rating downgrades of underlying corporate bonds and/or losses in cryptocurrency holdings. The company states that all CPOs are fully collateralized and that collateral is held in custody by U.S. Bank.

What are DelphX Collateralized Reference Notes (CRNs)?

DelphX describes Collateralized Reference Notes (CRNs) as proprietary instruments that allow investors to take on a capped rating-downgrade and/or cryptocurrency-loss exposure of an underlying security or cryptocurrency in exchange for potential returns. Like CPOs, CRNs are represented as fully collateralized with collateral held by U.S. Bank.

What is the Quantem Crypto Securities (QCS) program?

The Quantem Crypto Securities (QCS) program is described by DelphX as a fully collateralized hedging solution aimed at digital-asset treasuries and other institutional participants. QCS is intended to provide a structured mechanism for mitigating volatility and protecting crypto-asset treasury holdings, particularly Bitcoin, through collateralized contracts offered via the Quantem LLC vehicle.

How does DelphX work with broker-dealers?

DelphX states that, through Quantem LLC, it enables broker-dealers to offer new private placement securities to their qualified institutional buyer accounts. These securities include CPOs and CRNs, which broker-dealers can structure, sell, and make markets in, subject to applicable regulatory and market conditions.

On which markets does DelphX Capital Markets Inc. trade?

DelphX has disclosed that its shares trade on the TSX Venture Exchange under the symbol DELX and on the OTCQB market under the symbol DPXCF. These listings provide access to both Canadian and U.S. over-the-counter investors.

How are DelphX’s structured products collateralized?

In its public descriptions, DelphX emphasizes that all Collateralized Put Options (CPOs) and Collateralized Reference Notes (CRNs) are fully collateralized. The company reports that the collateral backing these instruments is held in custody by U.S. Bank.

How does DelphX raise capital for its operations?

DelphX has reported using non-brokered private placements of units consisting of common shares and common share purchase warrants. The company has stated that net proceeds from these offerings are intended for working capital, corporate overhead, or general corporate purposes, subject to TSX Venture Exchange approval and applicable hold periods.

What risks does DelphX highlight regarding its crypto-related activities?

DelphX notes that the crypto market is high risk and subject to significant volatility. In connection with its Quantem Crypto Securities program, the company presents QCS as a fully collateralized hedging solution for digital-asset treasuries, while also stating that there can be no assurance that contemplated collaborations, implementations, or transactions will be completed.

What is the nature of DelphX’s letter of intent with Belgravia Hartford Capital Inc.?

DelphX has announced a non-binding letter of intent with Belgravia Hartford Capital Inc. regarding the first anticipated commercial transaction of its Quantem Crypto Security. Under this LOI, Belgravia is expected to become the first corporate purchaser of a QCS collateralized put option designed to protect corporate Bitcoin treasury holdings, subject to definitive documentation, regulatory approvals, market conditions, and other customary closing conditions.